Mike Kelly bought Abbott Laboratories (NYSE: ABT)
Mike Kelly (R-PA), a U.S. Representative, has disclosed 3 trades in Abbott Laboratories (ABT) since 2015, 1 purchase and 2 sales, worth an estimated $49K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Mike Kelly bought $1,001 - $15,000 of Abbott Laboratories (NYSE: ABT) on April 13, 2016. Since that trade, ABT is up +200.46% against the S&P 500 up +312.80%, an outperformance of -112.33%.
Across these filings, Mike Kelly has been a net seller of ABT (a buy-to-sell ratio of 0.50). The most recent disclosed ABT transaction shown was dated December 8, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Mike Kelly's ABT trades vs the price
ABT is up +200.46% since Mike Kelly bought on April 13, 2016, versus +312.80% for the S&P 500.
Performance since this trade
All Mike Kelly ABT trades
Mike Kelly & ABT trading FAQ
Is it legal for Mike Kelly to trade Abbott Laboratories (ABT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mike Kelly buy ABT?
Mike Kelly disclosed a purchase of $1,001 - $15,000 of Abbott Laboratories (ABT) on April 13, 2016, according to public STOCK Act filings.
How has ABT performed since Mike Kelly's trade?
Since Mike Kelly bought ABT on April 13, 2016, the stock is up +200.46%, versus +312.80% for the S&P 500 over the same period, an outperformance of -112.33%.
How many times has Mike Kelly traded ABT?
Mike Kelly has disclosed 3 ABT trades since 2015 (1 purchase and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABT trades?
Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.
Mike Kelly's ABT tradesAll congressional filings for Abbott LaboratoriesMike Kelly's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.